Finance

Lists
3692:HKG
Hansoh Pharmaceutical Group Company Ltd
31,74 HK$
+1,15%
(+0,36) 1D
16 հոկ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3692...
Open
31,72 HK$
High
32,44 HK$
Low
31,52 HK$
Mkt. cap
192,48 մլրդ
Avg. vol.
8,58 մլն
Volume
10,50 մլն
Dividend
1,53%
Quarterly dividend
0,12 HK$
Ex-dividend date
22 սեպ, 2026 թ.
P/E ratio
24,51
52-wk high
44,22 HK$
52-wk low
28,06 HK$
EPS
1,30 HK$
No. of employees
10 հզր
Open
31,72 HK$
High
32,44 HK$
Low
31,52 HK$
Mkt. cap
192,48 մլրդ
Avg. vol.
8,58 մլն
Volume
10,50 մլն
Dividend
1,53%
Quarterly dividend
0,12 HK$
Ex-dividend date
22 սեպ, 2026 թ.
P/E ratio
24,51
52-wk high
44,22 HK$
52-wk low
28,06 HK$
EPS
1,30 HK$
No. of employees
10 հզր
News stories
From web sources and news partners
Profile
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China. Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019. In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
About Hansoh Pharmaceutical Group Company Ltd
CEO-
Employees9,64 հզր
Founded1995
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
3,80 մլրդ
3,80 մլրդ
4,15 մլրդ
4,15 մլրդ
Cost of goods sold
420,88 մլն
420,88 մլն
336,81 մլն
336,81 մլն
Cost of revenue
420,88 մլն
420,88 մլն
336,81 մլն
336,81 մլն
Research and development expenses
958,57 մլն
958,57 մլն
869,69 մլն
869,69 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,29 մլրդ
1,29 մլրդ
1,09 մլրդ
1,09 մլրդ
Operating expense
2,25 մլրդ
2,25 մլրդ
1,97 մլրդ
1,97 մլրդ
Total operating expenses
2,67 մլրդ
2,67 մլրդ
2,31 մլրդ
2,31 մլրդ
Operating income
1,12 մլրդ
1,12 մլրդ
1,84 մլրդ
1,84 մլրդ
Other non operating income
31,11 մլն
31,11 մլն
28,34 մլն
28,34 մլն
EBT including unusual items
1,43 մլրդ
1,43 մլրդ
2,50 մլրդ
2,50 մլրդ
EBT excluding unusual items
1,42 մլրդ
1,42 մլրդ
2,46 մլրդ
2,46 մլրդ
Income tax expense
220,95 մլն
220,95 մլն
375,70 մլն
375,70 մլն
Effective tax rate
15,44%
15,44%
15,00%
15,00%
Other operating expenses
6,65 մլն
6,65 մլն
9,48 մլն
9,48 մլն
Net income
1,21 մլրդ
1,21 մլրդ
2,13 մլրդ
2,13 մլրդ
Net profit margin
31,87%
31,87%
51,28%
51,28%
Earnings per share
-
-
-
-
Interest and investment income
284,14 մլն
284,14 մլն
630,79 մլն
630,79 մլն
Interest expense
-764,50 հզր
-764,50 հզր
-24,31 մլն
-24,31 մլն
Net interest expenses
283,37 մլն
283,37 մլն
606,48 մլն
606,48 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,21 մլրդ
1,21 մլրդ
1,93 մլրդ
1,93 մլրդ
Gain or loss from assets sale
-1,70 մլն
-1,70 մլն
-5,55 մլն
-5,55 մլն
AI content may include mistakes. Learn more
Google Apps